Clinical Trials
3 trialsNCT05679050 2023-01-10
Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT04810910 2021-11-16
Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Zhejiang Provincial People's Hospital
Phase 1 Unknown
NCT04737551 2021-02-04
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study
Shanghai Zhongshan Hospital
Unknown